mg/L, P < 0.001). ‹naktif ülseratif kolitli hastalar ve kontrol grubu aras›nda fark saptanmad› (P > 0.05). Kalprotektin konsantrasyonu, daha ciddi klinik indeksi, yük-sek endoskopik aktivitesi (>4), artm›fl C-reaktif proteini, lökositozu ve ekstensif koliti olan hastalarda daha yüksekti (P < 0.05). E¤-ri alt›ndaki alan, C-reaktif (95% confidence interval: 232.5 (0.75-625) vs 11.7 (0.2-625), 7.5 (0.5-512) 
INTRODUCTION
Assessment of intestinal inflammation in inflammatory bowel diseases (IBDs) remains a difficult challenge. Endoscopy with biopsy sampling, as the most reliable method, is an invasive diagnostic tool. Several markers including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), acid glycoprotein (AGP), and platelet count have been used for the determination of disease activity in ulcerative colitis (UC) (1-7), but none of them is specific for gut inflammation. Clinical indices of disease activity, such as the ulcerative colitis activity index (UCAI) and Truelove-Witts criteria reflect the patient's well-being and quality of life rather than the degree of mucosal inflammation.
A prominent feature of mucosal histology in patients with active IBD is infiltration by neutrophil granulocytes (8) . Calprotectin is a major protein of neutrophils and macrophages and it accounts for about 60% of the cytosol of these cells (9) . This protein can resist metabolic degradation caused by intestinal bacteria, and it is relatively stable in stools for up to one week at room temperature (10) . Several studies have shown that elevated fecal calprotectin (FC) levels correlate with intestinal inflammation, both in adults and children (11) (12) , and monitoring of FC level has the ability to predict relapse in IBD (13, 14) .
The aim of the present study was to reveal the role of FC in determining disease activity in UC by looking at relationships among FC, peripheral blood neutrophils, CRP, modified Truelove-Witts activity index, and endoscopic mucosal appearance defined by Rachmilewitz (15, 16) .
MATERIALS AND METHODS
Sixty patients with UC (age: 49.7±10.7 years) were enrolled in the study, including 21 patients with proctitis, 33 with left-sided colitis, and 9 with extensive colitis. Laboratory parameters included hemoglobin (Hb) (ranges: 14-18 g/dl for men, 12-16 g/dl for women), white blood cell count (WBC) (range: 4,000-10,000/mm 3 ), neutrophil count (range: 1,800-6400/mm 3 ), platelet count (range: 150,000-450,000/mm 3 ), ESR (range: 0-20 mm/hr), and CRP (0-7.44 mg/dl). Rectosigmoidoscopy was performed in all patients. The patients' disease activities were assessed according to the modified Truelove-Witts Severity Index and Rachmilewitz endoscopic index (15, 16) . The patients with inactive UC had been in clinical remission for at least one year. The control group consisted of 20 subjects (age: 50.8±11.9 years) with no confirmed abnormality in the upper or lower digestive tract. The study was approved by the Local Ethics Committee (report no: B.10.4.ISM.4.06.00.15).
The stool samples of the patients were collected in plastic containers and stored at -70°C until the time of measurement. The stool samples were thawed and 100 mg of the sample measured by the use of a stool sample preparation kit (Roche Diagnostics, Manheim, Germany) was suspended in 5 ml extraction buffer. Following homogenization, the supernatant was diluted to 1:50 and the calprotectin level was analyzed quantitatively by enzyme-linked immunosorbent assay (ELISA) using PhiCal Calprotectin ELISA kit (Immundiagnostik AG, Bensheim, Germany). The results were read as absorbance values obtained at 450 nm. To obtain the calprotectin concentration in stool samples, the estimated value from the standard curves was multiplied by the dilution factor (2500) and the results were expressed as mg/L.
Parametric data are presented as mean±SD, range, and median values, or as indicated otherwise. For categorical variables, percentages were provided. Categorical variables were compared with the X 2 test. A Kolmogorov-Smirnov test was used to evaluate whether FC values followed a normal (Gaussian) distribution. The Mann-Whitney test and unpaired t test were used to assess differences in the laboratory parameters between the groups, and Spearman's correlation was used to analyze the correlation between the parameters. All the p values were two tailed; p values <0.05 were considered statistically significant. The receiver operating characteristics (ROC) (sensitivity and specificity) were assessed by the curve analysis as described by Henderson (17) .
RESULTS
There was a significant difference in the calprotectin concentration between the patients with active UC and the patients with inactive UC (p<0.01) (Table 1, Figure 1 ). The calprotectin concentration was greater in the patients with inactive UC than in the controls, but the difference was not significant (p>0.05) (Table 1, Figure 1 ). The patients with active UC had higher levels of CRP, ESR and leukocyte count than the patients with inactive UC and the controls, but the only significant difference was observed in CRP (Table 1 ). There was no significant difference between the patients with inactive UC and the controls regarding these parameters (p>0.05) ( Table 1 ). The calprotectin concentration was greater in the patients with a more severe clinical index, a high index of endoscopic activity (EAI), elevated CRP, leukocytosis, and extensive colitis (p<0.05) ( Table 2 ). As shown in Table 3 F Fi ig gu ur re e 2 2. . The ROC curve analysis on the abilities of calprotectin, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and leukocyte count to distinguish between active and inactive ulcerative colitis.
DISCUSSION
In the present study, we evaluated FC as a surrogate marker of disease activity in UC. Our results showed that FC was a sensitive and reliable indicator of active disease in patients with UC. FC was also correlated with the degree of clinical activity as well as endoscopic severity. FC was the only parameter that was associated with the more extensive involvement in UC.
The neutrophils are the main sources of reactive oxygen derivatives, active lipids, inflammatory cytokines, and proteases. The presence of calprotectin in feces is directly proportional to neutrophil migration toward the intestinal tract (18) . The FC excretion of indium-labeled autologous granulocytes has been suggested as the gold standard test in assessing bowel inflammation in IBD. However, it involves an exposure to radiation and prolonged fecal collection (19) . On the other hand, FC measurement is a simple, harmless and noninvasive method. Our results agree with the previous studies that found that FC was a good marker for differentiation of active UC from inactive UC (11) (12) (13) (14) . Furthermore, FC was as effective as CRP and superior to ESR and leukocytosis as a discriminating parameter. FC, as well as CRP, was significantly correlated with clinical activity, and this finding was consistent with the literature (11, 20) . The correlation was stronger than the one between ESR and disease activity. These differences may result from the fact that FC is a local and direct marker of intestinal inflammation, whereas ESR and leukocytosis are systemic and indirect indicators of gastrointestinal disease.
Our data revealed a significant association between FC and endoscopic activity. Endoscopic findings have been shown to correlate with FC levels in patients with IBD (20, 21) . FC concentrations also correlate with histological findings, such that it was proposed to be a more sensitive indicator than endoscopy in evaluating IBD activity (22) . It is known that most of the IBD patients in clinical remission have residual inflammation in the colonic mucosa, and some of these develop symptomatic relapse over time (14, 23, 24) . A study showed that FC was useful in predicting impending clinical relapse -especially during the following three months-in IBD (25) . The authors also suggested that normalized FC level may be used as a marker for treatment response in patients with IBD (25).
However, it was reported that FC may better reflect disease activity in UC than in Crohn's disease (26) .
In our study, it was observed that for differentiation of active UC from inactive UC, sensitivity was highest for FC, and the cut-off value was determined to be 99.5 mg/L (Table 4 ). An optimal calprotectin cut-off point for predicting active IBD is not well defined. As the unit of FC, some studies used μg/g (13, 25) , whereas others preferred mg/L (20) . Another reason may be that the cut-off value differs accordingly to the specific assay used, and direct comparisons would only be valid if the same assay was being used. Furthermore, different cutoff values are suggested for different patient categories, higher for patients with known inflammatory conditions while lower for screening purposes (18) . Regarding its sensitivity and specificity and the absence of a universally accepted cut-off value, FC is not a gold standard test but rather an adjunctive method. All clinicians must be careful, since a false-negative FC test would lead to delayed treatment and continuation of symptoms, whereas a false-positive test would lead to an unnecessarily invasive endoscopy with possible complications from colonic perforation.
A large number of neutrophils infiltrate the mucosa in many infective diseases, such that FC is elevated in a number of organic gastrointestinal disorders (27, 28) . Therefore, FC could not be used as a marker to differentiate between UC and infective colitis. It has been suggested that FC has a good diagnostic precision for separating organic and functional intestinal diseases (29, 31) . However, we did not observe a significant difference between the patients with inactive UC and the controls in our series. We think that this subject necessitates further studies involving a more homogeneous and well-defined group of patients. FC cannot take the place of an endoscopic examination in the diagnosis of organic disease.
In conclusion, FC is a useful marker in the diagnosis of active disease and evaluation of clinical and endoscopic activity in UC. It can be used as an adjunct to endoscopic examination in clinical practice.
